Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT

NCT03899376
completednot_applicable

Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc

NCT01218542
unknownnot_applicable

Hypofractionated Radiation Therapy in Prostate Cancer

NCT01764646

Clinical Trials (3)

Showing 3 of 3 trials
NCT03899376Not Applicable

A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT

Unknown
NCT01218542Not Applicable

Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc

Completed
NCT01764646Not Applicable

Hypofractionated Radiation Therapy in Prostate Cancer

Unknown

All 3 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
3